Health Condition 1: C719- Malignant neoplasm of brain, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Homi Bhabha Cancer Hospital and Research Centre, Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: Glioma cases who received at least one of the adjuvant treatment in HBCHRC, Vizag.
Exclusion criteria
Exclusion criteria: Patients who received EBRT outside HBCHRC Patient with recurrent/progressive disease at presentation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate patterns of care in patients with glioma treated at HBCHRC, Vizag over January 1st , 2020 till December 31st , 2024Timepoint: 2 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess compliance to planned treatment protocols. 2. To assess documentation, completeness of diagnostic and staging workup, including MRI, histopathology and molecular markers 3. To evaluate treatment related toxicities and unplanned treatment interruptions 4. To assess follow-up patterns and imaging surveillance post treatment 5. To identify prognostic factors influencing PFS (Progression Free Survival) and OS (Overall Survival) 6. To identify gaps in care delivery and areas of quality improvement 7. To propose recommendations/ action plans 8. To assess follow-up patterns and imaging surveillance post treatment 9. To assess response to treatment as per RANO criteria Timepoint: 2 Years | — |
Countries
India
Contacts
Public ContactDr Umesh Mahantshetty
Homi Bhabha Cancer Hospital and Research Centre
Outcome results
None listed